SFL's Managing Director, Shayesteh Furst-Ladani will be giving presentations at two upcoming Swiss life science events on revision of EU Medtech legislation.
SFL Regulatory Affairs Consulting Ltd. (SFL) is pleased to be strengthening its activities in the UK and will be holding an inaugural and networking event in London on 8 October 2013.
SFL is pleased to announce that Shayesteh Fürst-Ladani, SFL's Managing Director, has been invited to give a presentation on the classification and regulation of drug/device combinations at the MEDTEC Europe event to be held in Stuttgart, Germany from 26 to 28 February 2013.
SFL Regulatory Affairs & Scientific Communication Ltd is proud to announce that the company has been selected as a finalist in the second annual British-Swiss Business Awards.
SFL will present at a one-day conference to provide delegates with an understanding of the regulatory framework for drug/device combinations and drug/companion diagnostics in the EU.
SFL's Managing Director to provide update on Revision of European Medical Device Directives to delegates at the DIA 48th Annual Meeting in Philadelphia.
SFL is pleased to announce that Dr Faiz Kermani, Senior Communication Manager, will be giving a presentation entitled "The Regulatory Framework for New Drug Innovation" at the 8th Annual Conference of the Pharmaceutical Contract Management Group.
SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be speaking at the upcoming Healthcare Businesswomen's Association European meeting entitled "The Role of Regulatory Affairs in Successful Development and Launch of Healthcare Products" to be held in Basel, Switzerland.
Presentations by senior staff of SFL on the EU regulation of medical devices and combination products drew a large and very interested audience at the recent conference in Zurich, Switzerland, organised by the Swiss Association of Pharmaceutical Professionals (SwAPP) and SGPM, the Swiss Society for Pharmaceutical Medicine.